Abstract:Id3 limits PD-1 expression and exuberant effector differentiation of Th1 cells, protecting them from PD-1-mediated suppression during GVHD Id3 reduces chromatin accessibility of transcription factors that drive T cell PD-1 transcription, differentiation and dysfunction Persisting alloreactive donor T cells in target tissues are a determinant of graft-versus-host disease (GVHD), but the transcriptional regulators that control the persistence and function of tissue-infiltrating T cells remain elusive. We demonstrate here that Id3, a DNA-binding inhibitor, is critical for sustaining T cell responses in GVHD target tissues in mice, including the liver and intestine. Id3 loss results in aberrantly expressed PD-1 in polyfunctional Th1 cells, decreased tissue-infiltrating PD-1 + polyfunctional Th1 cell numbers, impaired maintenance of liver TCF-1 + progenitor-like T cells, and inhibition of GVHD. PD-1 blockade restores the capacity of Id3-ablated donor T cells to mediate GVHD. Single-cell RNA-sequencing analysis revealed that Id3 loss leads to significantly decreased CD28- and PI3K/AKT-signaling activity in tissue-infiltrating polyfunctional Th1 cells, an indicator of active PD-1/PD-L1 effects. Id3 is also required for protecting CD8 + T cells from the PD-1 pathway-mediated suppression during GVHD. Genome-wide RNA-sequencing analysis reveals that Id3 represses transcription factors (e.g., Nfatc2 , Fos , Jun , Ets1 , Prdm1 ) that are critical for PD-1 transcription, exuberant effector differentiation, and IFN responses and dysfunction of activated T cells. Id3 achieves these effects by restraining the chromatin accessibility for these transcription factors. Id3 ablation in donor T cells preserved their graft-versus-tumor effects in mice undergoing allo-HSCT. Furthermore, CRIPSR/Cas9 knockout of ID3 in human CD19-directed CAR-T cells retained their anti-leukemia activity in NOD/SCID/IL2Rg −/− mice early after administration. These findings identify that ID3 is an important target to reduce GVHD, and gene-editing program of ID3 may have broad implications in T cell-based immunotherapy.

The DNA-binding Inhibitor Id3 Regulates IL-9 Production in CD4 + T Cells

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Distinct Functions for the Transcription Factors GATA-3 and ThPOK During Intrathymic Differentiation of CD4+ T Cells

Cutting Edge: Smad2 and Smad4 Regulate TGF-β-mediated Il9 Gene Expression Via EZH2 Displacement.

IL-1β promotes IL-9-producing Th cell differentiation in IL-2-limiting conditions through the inhibition of BCL6

Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation.

Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis

Id1 Expression Promotes Peripheral Cd4(+) T Cell Proliferation and Survival Upon Tcr Activation Without Co-Stimulation

Id1 expression in CD4 T cells promotes differentiation and function of follicular helper T cells and upregulation of related functional molecules

Distinct regulatory roles for Janus Tyrosine Kinase 3 (Jak3) in generation of T-helper 17 (TH17) and inducible regulatory T cells (Tregs) (47.10)

DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells

Smad3 Differentially Regulates the Induction of Regulatory and Inflammatory T Cell Differentiation

Activin A Promotes Differentiation of a Pathogenic Multicytokine IL-9-secreting CD4+ T Cell Population

Tissue-infiltrating Alloreactive T Cells Require Id3 to Deflect PD-1-mediated Immune Suppression during GVHD

Up-regulated DNA-binding Inhibitor Id3 Promotes Differentiation of Regulatory T Cell to Influence Antiviral Immunity in Chronic Hepatitis B Virus Infection

A CTCF-binding site in the Mdm1-Il22-Ifng locus shapes cytokine expression profiles and plays a critical role in early Th1 cell fate specification

Identification of a transcription factor network regulating anti-TNF mediated IL10 expression in human CD4+ T cells